Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2017, Article ID 6464972, 4 pages
https://doi.org/10.1155/2017/6464972
Clinical Study

Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia

1Department of Pharmacy, West Virginia University Medicine, Morgantown, WV, USA
2Section of Hematology/Oncology, Department of Internal Medicine, West Virginia University, Morgantown, WV, USA
3Osborn Hematopoietic Malignancy and Transplantation Program, MBRCC, West Virginia University, Morgantown, WV, USA

Correspondence should be addressed to Aaron Cumpston; gro.enicidemuvw@anotspmuc

Received 28 March 2017; Accepted 27 April 2017; Published 14 May 2017

Academic Editor: Meral Beksac

Copyright © 2017 Brandi Anders et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Brandi Anders, Lauren Veltri, Abraham S. Kanate, et al., “Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia,” Advances in Hematology, vol. 2017, Article ID 6464972, 4 pages, 2017. https://doi.org/10.1155/2017/6464972.